Corcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session Corcept Therapeutics Incorporated a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the…
Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD)…
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo Arrowhead Pharmaceuticals, Inc. announced long-term efficacy and safety data from a two-year long…
Alpha Cognition Inc. Reports Fiscal 2025 Financial Results and Provides Operational Update Alpha Cognition Inc. a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025,…
Aledade Partners Achieve Superior Hypertension Control Outperforming Large Health Systems in New Case Study Aledade, a physician-led, national leader in value-based care, announced the results of a new case study demonstrating how its network of primary care clinicians is successfully controlling hypertension…
Nordic Cold Chain Solutions Launches GLP-1 & Small-Format Packaging Innovation Lab Nordic Cold Chain Solutions today announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a customer-first initiative designed to help specialty pharmacies, pharmaceutical manufacturers, and e-commerce leaders…
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company’s investigational small…
Healthcare Digital Wins 2026 Artificial Intelligence Excellence Award for Nutrition AI, Developed in Collaboration with Morrison Healthcare Healthcare Digital, the healthcare and senior living division of Compass Digital and the technology arm for Compass Healthcare, today announced it has been named a winner…
Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations Xaira Therapeutics announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and Operations, reporting to President and COO Jeff…
Bayer Crop Science Canada Redefines Canola Innovation With New “Advancing Better Canola” Initiative Bayer Crop Science Canada launches Advancing Better Canola (ABCs), an industry-wide initiative to challenge and redefine how it thinks about canola innovation in support of Canadian farmers.…
Abcuro Presents Results from Phase 2/3 MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis at GCOM 2026 Abcuro, Inc., a clinical stage biotechnology company, today presented results at the 6th Global Conference on Myositis (GCOM) meeting, being held March 23-26, 2026…
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of clinical and real‑world data across its portfolio…